Lumefantrine N-Oxide

Product Description
CAT No.
ALN-L058009
CAS No.
NA
Mol. F.
C30H32Cl3NO2
Mol. Wt.
544.9
Stock
In Stock
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (Z)-N-butyl-N-(2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)-2-hydroxyethyl)butan-1-amine oxide
Smiles : CCCC[N+](CCCC)([O-])CC(O)C1=CC(Cl)=CC2=C1C3=C(/C2=C/C4=CC=C(Cl)C=C4)C=C(Cl)C=C3
Inchi : InChI=1S/C30H30Cl3N/c1-3-5-14-34(15-6-4-2)16-13-22-18-25(33)20-29-27(17-21-7-9-23(31)10-8-21)28-19-24(32)11-12-26(28)30(22)29/h7-13,16-20H,3-6,14-15H2,1-2H3/b16-13-,27-17-
Technical Data
Reference
Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine
Mathieu Verbeken1u2020 , Sultan Suleman1,3u2020 , Bram Baert1 , Elien Vangheluwe1 , Sylvia Van Dorpe1 , Christian Burvenich2 , Luc Duchateau2 , Frans H Jansen4 , Bart De SpiegeleernVerbeken et al. Malaria Journal 2011, 10:51 Page 2 of 9
Analytical Method Development and Validation for Estimation of Lumifantrine in Pharmaceutical Dosage Forms by HPLC
Naveen S Kotur
A Modified Method for Determination of Lumefantrine in Human Plasma by HPLC-UV and Combination of Protein Precipitation and Solid-Phase Extraction: Application to a Pharmacokinetic Study
1 ,Singaravel Sivasamy2 , S.Srinivasan – J. Pharm. Sci. & Res. Vol.4(1), 2012,1672-1675
RFQ